Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Tirzepatide Tirzepatide is a dual agonist that targets both the glucose-dependent insulinotropic polypeptide (GIP) and the GLP-1 receptor
The drugs have similar side effects to the injectables, including nausea and diarrhea
Primary care doctors raise alarm as telehealth companies get involved in obesity drugs GLP-1 apps raise hurdles For stories on healthy living, subscribe to NPR's Health newsletter
Both medications are effective, but tirzepatide's greater average effect size has made it the faster-growing segment of the GLP-1 market
US$ 23.90
US$ 23.99
US$ 29.90
